Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous Glucose Monitoring To Type 2 Diabetes Patients. This recall involves ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small ... Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To ...

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Abbott Laboratories' diabetes ... CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin users). A simpler, more targeted option ...

Over the past few years, Abbott Laboratories' (NYSE ... CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin users).

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...